Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
9
2020
 FDA Provides Congressionally-Mandated Cannabidiol (CBD) Report but Reveals Little Progress Keller and Heckman LLP
Mar
9
2020
 EPA Releases Supplemental Proposed Rule to the Proposed Rule on Strengthening Transparency in Regulatory Science Bergeson & Campbell, P.C.
Mar
9
2020
 Florida Federal District Court Rules GRAS Regulation Preempts Florida Statute Criminalizing Ingredient McDermott Will & Schulte LLP
Mar
7
2020
 Mississippi Supreme Court Rejects ‘Passage of Title’ DTC Theory McDermott Will & Schulte LLP
Mar
7
2020
 FDA Launches New “Feed Your Mind” Initiative to Increase Consumer Understanding of Genetically Engineered Foods Keller and Heckman LLP
Mar
6
2020
 First DOJ Enforcement under New Opioids Kickback Law Announced Dinsmore & Shohl LLP
Mar
6
2020
 Can the DOJ Really Prosecute State-Legal Marijuana Entities? Dinsmore & Shohl LLP
Mar
6
2020
 Managing the Commercial Impact of the Coronavirus: Food & Beverage Foley & Lardner LLP
Mar
6
2020
 EPA Releases List of Disinfectants for Use against COVID-19 Bergeson & Campbell, P.C.
Mar
5
2020
 Clinical Trial Results Will See Daylight After HHS Final Rule Is Set Aside Mintz
Mar
5
2020
 Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison Fulton [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Mar
5
2020
 Antitrust Liability Risk When Listing Patents in Orange Book McDermott Will & Schulte LLP
Mar
5
2020
 How FDA is Reacting to the Coronavirus, and 2020 Regulatory Priorities Sheppard, Mullin, Richter & Hampton LLP
Mar
5
2020
 Dairy Industry Urges FDA to Prohibit the Use of Traditional Dairy Terms on Plant-Based Products Keller and Heckman LLP
Mar
5
2020
 Comments on Proposed Supplemental SNUR on LCPFAC Chemical Substances Due April 17 Bergeson & Campbell, P.C.
Mar
5
2020
 NIOSH CIB on Practices in Occupational Risk Assessment Addresses Nanomaterials Bergeson & Campbell, P.C.
Mar
4
2020
 FDA’s Evolving Response to the COVID-19 (Coronavirus) Outbreak Mintz
Mar
4
2020
 Federal Preemption in the Wake of Albrecht: The U.S. Supreme Court Unexpectedly Levels the Playing Field Sills Cummis & Gross P.C.
Mar
4
2020
 What COVID-19 Means for FDA-Regulated Industry Polsinelli PC
Mar
4
2020
 In Enforcement Action, SEC Underscores Heightened Scrutiny of KPIs in MD&A Reporting Faegre Drinker
Mar
4
2020
 The 2019 Honig Act Means New Obligations for New Jersey Employers Around Cannabis at Work Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
4
2020
 Proposed Class Action Urges Court Not to Dismiss Suit Against Florida CBD Manufacturer Keller and Heckman LLP
Mar
3
2020
 FDA Finalizes Clinical Laboratory Guidance Documents For In Vitro Diagnostic Tests Barnes & Thornburg LLP
Mar
3
2020
 PFAS Update: EPA Begins Process of Developing Drinking Water Limits for PFOS and PFOA Greenberg Traurig, LLP
Mar
3
2020
 EFSA Publishes Draft Scientific Opinion on PFASs in Food Keller and Heckman LLP
Mar
3
2020
 Disposables are Making Vaping Harder to Detect Among Teens Stark & Stark
Mar
3
2020
 EPA Extends Comment Period for Proposed Registration Decision for New Nanosilver Product Bergeson & Campbell, P.C.
Mar
2
2020
 FDA Launches Limited Pilot Program For Interactive 510(K) Application Barnes & Thornburg LLP
Displaying 5909 - 5936 of 12597
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters